Stock A002620 JEIL PHARMA HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Jeil Pharma Holdings Inc

Equities

A002620

KR7002620003

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 04/07/2024 BST 		5-day change 1st Jan Change
9,820 KRW +0.41% Intraday chart for Jeil Pharma Holdings Inc -0.51% -16.57%
2023 Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.
CI
Jeil Pharma Holdings Inc completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 250 billion.
CI
Jeil Pharma Holdings Inc made an offer to acquire an additional 47.6% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 490 billion.
CI
Jeil Pharma Holdings Inc acquired 13.53% stake in Jeil Pharmaceutical Co.,Ltd.
CI
Jeil Pharma Holdings Inc's Equity Buyback announced on August 28, 2015, has expired.
CI
Jeil Pharma Holdings Inc's Equity Buyback announced on November 7, 2013, has expired.
CI
Jeil Pharmaceutical Co., Ltd. announced the spin-off of its pharmaceuticals manufacturing and sales business.
CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2017.
CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till August 26, 2017.
CI
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on August 28, 2015.
CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2016.
CI
Jeil Pharma Holdings Inc announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Jeil Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till November 7, 2013.
CI
Fidelity Management & Research Company and three related parties acquired 11.58% stake in Jeil Pharmaceutical Co., Ltd..
CI
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on November 7, 2013.
CI
Jeil Pharmaceutical Co., Ltd.’s Equity Buyback announced on January 31, 2013 has expired.
CI
Jeil Pharma Holdings Inc announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A002620 Stock
  4. News Jeil Pharma Holdings Inc
  5. Highlights